P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
PGEN | N/A | N/A | N/A | +54.52% |
PGEN Peer | N/A | N/A | N/A | -5.57% |
Biotechnology Industry | 18.6 | 17.3 | 0.4 | +651.19% |
Health Technology Sector | 31.9 | 21.0 | 0.6 | +119.66% |
S&P 500 Market | 31.0 | 30.6 | 1.0 | +99.36% |
Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
---|---|---|---|---|
Mean Estimate | -$0.05 | -$0.13 | -$0.13 | -$0.20 |
Previous Mean | -$0.04 | -$0.13 | N/A | N/A |
Standard Deviation | 0.14 | 0.04 | 0.04 | N/A |
Low Estimate | -$0.14 | -$0.16 | -$0.17 | -$0.20 |
High Estimate | $0.19 | -$0.08 | -$0.08 | -$0.20 |